Spots Global Cancer Trial Database for stereotactic body radiotherapy
Every month we try and update this database with for stereotactic body radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
| Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) | NCT06251492 | Prostate Cancer... Castration-resi... | Stereotactic bo... Adebrelimab | 18 Years - 75 Years | Fudan University | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma. | NCT02821182 | Melanoma | stereotactic bo... | 18 Years - | University Hospital, Ghent | |
| Improving REsectability in Pancreatic NEoplasms (IRENE) | NCT03460925 | Pancreatic Canc... Stereotactic Bo... | SBRT plus chemo... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | NCT03159676 | Prostate Cancer | Proton beam | 18 Years - | Mayo Clinic | |
| A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer | NCT05079698 | Prostate Cancer | 177Lu-PSMA-617 Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gut Microbiota And Radiotherapy | NCT02559349 | Lung Tumor | Stool Collectio... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT | NCT05919641 | Non-small Cell ... Stereotactic Bo... Comprehensive G... | Comprehensive G... | 70 Years - | Odense University Hospital | |
| Evaluation of Effectiveness of CyberKnife Stereotactic Radiosurgery for Spinal Tumors | NCT04192383 | Spinal Neoplasm... | Cyberknife ster... | - | Peking University Third Hospital | |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors | NCT05915481 | Advanced Solid ... Stereotactic Bo... Immune Checkpoi... Safety Efficacy | Cadonilimab Stereotactic bo... | 18 Years - 75 Years | Peking University Third Hospital | |
| Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence | NCT03438552 | Local Recurrenc... | Stereotactic Bo... | 18 Years - | UNICANCER | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma | NCT01586182 | Squamous Cell C... | Stereotactic Bo... | 18 Years - 80 Years | Dana-Farber Cancer Institute | |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | NCT01511081 | Non-small-cell ... | SBRT (stereotac... SBPT (stereotac... | 18 Years - | M.D. Anderson Cancer Center | |
| Post SBRT Pulmonary Metastasectomy (PSPM) Trial | NCT04160143 | Surgical Resect... Stereotactic Bo... Lung Cancer Pulmonary Metas... | Surgical resect... | 18 Years - | McMaster University | |
| Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis | NCT01569984 | Colorectal Canc... | Stereotactic bo... | 18 Years - | Sunnybrook Health Sciences Centre | |
| SCION: SABR and Checkpoint Inhibition Of NSCLC | NCT04944173 | Non Small Cell ... Carcinoma, Non-... Non-small Cell ... Lung Cancer Lung Cancer Sta... Lung Adenocarci... Lung Squamous C... | Durvalumab Stereotactic Bo... Circulating Tum... | 18 Years - | University of British Columbia | |
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer | NCT04262154 | Metastatic Pros... | Atezolizumab Abiraterone Prednisone GnRH analog Stereotactic Bo... Enzalutamide Follow up | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) | NCT04167293 | Hepatocellular ... | stereotactic bo... Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Evaluation of Single Session Stereotactic Body Radiotherapy | NCT00492817 | Spinal Neoplasm... | Stereotactic Bo... | - | M.D. Anderson Cancer Center | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma | NCT04986930 | Pancreatic Aden... Pancreatic Canc... | SBRT+mFOLFIRINO... mFOLFIRINOX | 19 Years - | Asan Medical Center | |
| Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection | NCT01326364 | Pancreatic Canc... | Stereotactic bo... Iodixanol Iohexol | 18 Years - | Stanford University | |
| 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | NCT04610372 | Oligometastatic... | Hypofractionate... High dose rate ... Permanent seed ... Stereotactic bo... | 18 Years - | British Columbia Cancer Agency | |
| Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT | NCT05023265 | Renal Cell Carc... | Stereotactic bo... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy | NCT05916040 | Rectal Cancer | Radiotherapy wi... Questionnaires ... | 18 Years - | Universitair Ziekenhuis Brussel | |
| Stereotactic Body Radiotherapy for Prostate Cancer | NCT01352598 | Prostate Cancer | stereotactic bo... | 18 Years - | Mercy Research | |
| Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer | NCT06195254 | Stereotactic Bo... PD-1 Inhibitors Pancreatic Canc... | Stereotactic bo... PD-1 blocking a... | 18 Years - 80 Years | Peking University Third Hospital | |
| Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study) | NCT02853162 | Renal Cell Carc... | ARREST-study | 18 Years - 100 Years | UMC Utrecht | |
| Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients | NCT02441270 | Radiotherapy Immunology | Cyclophosphamid... Stereotactic bo... | 18 Years - | University Hospital, Ghent | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | NCT02313298 | Prostate Cancer | Stereotactic Bo... | 21 Years - | National Cancer Centre, Singapore | |
| Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT | NCT02344667 | Prostatic Neopl... | Stereotactic Bo... | 18 Years - | Juravinski Cancer Center | |
| Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. | NCT05615142 | NSCLC Low Dose Radiot... Stereotactic Bo... PD-1 Inhibitor | Low Dose Radiot... stereotactic bo... PD-1 Inhibitors | 18 Years - | Sichuan University | |
| Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer | NCT02416609 | Pancreatic Canc... | LDR Gem-based doubl... SBRT | 18 Years - | Azienda Ospedaliero-Universitaria di Modena | |
| Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: | NCT03875573 | Luminal B | Durvalumab Stereotactic Bo... Oleclumab | 18 Years - | Jules Bordet Institute | |
| mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma | NCT04986930 | Pancreatic Aden... Pancreatic Canc... | SBRT+mFOLFIRINO... mFOLFIRINOX | 19 Years - | Asan Medical Center | |
| Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT | NCT06408753 | Hepatocellular ... Stereotactic Bo... | sterotatic body... | 18 Years - | The University of Hong Kong | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer | NCT03203304 | Hepatocellular ... | Nivolumab Ipilimumab | 18 Years - | University of Chicago | |
| Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition | NCT03275597 | Non-small Cell ... Non-small Cell ... | Durvalumab Tremelimumab Stereotactic Bo... | 18 Years - | University of Wisconsin, Madison | |
| Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer | NCT04271384 | Non-small Cell ... | nivolumab | 18 Years - | Hospital Israelita Albert Einstein | |
| Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma | NCT03609151 | Hepatocellular ... Hepatectomy Stereotactic Bo... | laparoscopic he... stereotactic bo... | 18 Years - 80 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer | NCT00350142 | Pancreatic Canc... | Stereotactic Bo... Gemcitabine 4D pancreatic p... FDG PET scan | 18 Years - 90 Years | Stanford University | |
| A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT) | NCT03072979 | Spine Metastasi... | Stereotactic bo... | 21 Years - | National University Hospital, Singapore | |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | NCT04045717 | Prostate Adenoc... Prostate Cancer Prostate Neopla... | Hypo-FLAME 2.0 ... | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days | NCT04896801 | Prostate Cancer | MR-guided RT | 18 Years - | Universitair Ziekenhuis Brussel | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402) | NCT06313190 | Hepatocellular ... | Stereotactic bo... Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | NCT01304160 | Pancreatic Canc... Unresectable Pa... | stereotactic bo... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Stereotactic Body Radiotherapy for Liver Tumors | NCT01347333 | Liver Metastase... Hepatocellular ... Intrahepatic Ch... | Stereotactic bo... Stereotactic Bo... | 18 Years - | Mercy Research | |
| A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer | NCT04951115 | Small-cell Lung... | Carboplatin Cisplatin Etoposide Durvalumab Stereotactic Bo... | 18 Years - | Weill Medical College of Cornell University | |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc | NCT06084338 | Prostate Cancer | stereotactic ab... Pluvicto topical testost... | 18 Years - | VA Office of Research and Development | |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | NCT01151761 | Cholangiocarcin... Hepatobiliary N... Liver Cancer Bile Duct Cance... Cancer of Gallb... | Stereotactic Bo... Gemcitabine Cisplatin Carboplatin Capecitabine 5FU Liver transplan... | 18 Years - | Stanford University | |
| Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer | NCT03574220 | Non Small Cell ... | Pembrolizumab Stereotactic bo... | 18 Years - | Case Comprehensive Cancer Center | |
| Gut Microbiota And Radiotherapy | NCT02559349 | Lung Tumor | Stool Collectio... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC | NCT00246181 | Non-small Cell ... | radiation thera... | 18 Years - | Indiana University | |
| A Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases | NCT03831243 | Metastasis to B... Radiotherapy Neoplasm Metast... | Stereotactic bo... 3D-conformal ra... | 18 Years - | Cancer Research Antwerp | |
| Intraoperative Radiotherapy in Treating Spinal Metastases | NCT06093854 | Spinal Metastas... | Intraoperative ... Stereotactic bo... | 35 Years - 75 Years | Shanghai Changzheng Hospital | |
| Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer | NCT03203304 | Hepatocellular ... | Nivolumab Ipilimumab | 18 Years - | University of Chicago | |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | NCT04498767 | Gynecologic Can... Skin Cancer Head and Neck C... Sarcoma Renal Cancer Bladder Cancer Upper Urinary T... Pancreatic Canc... Hepatobiliary C... Gastric Cancer Small Bowel Can... Esophageal Canc... Melanoma Colon Cancer Oligometastasis | Stereotactic bo... Palliative RT | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| SBRT for Breast Cancer Oligometastases | NCT04424732 | Breast Neoplasm... | Stereotactic Bo... | 18 Years - | King Hussein Cancer Center | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) | NCT06251492 | Prostate Cancer... Castration-resi... | Stereotactic bo... Adebrelimab | 18 Years - 75 Years | Fudan University | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma | NCT02319889 | Stage I Non-Sma... Stage II Non-Sm... | Stereotactic Bo... Carboplatin Paclitaxel Albu... | 18 Years - | Case Comprehensive Cancer Center | |
| TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer | NCT04552509 | Prostate Cancer | Stereotactic Bo... | - | MemorialCare Health System | |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors | NCT05915481 | Advanced Solid ... Stereotactic Bo... Immune Checkpoi... Safety Efficacy | Cadonilimab Stereotactic bo... | 18 Years - 75 Years | Peking University Third Hospital | |
| Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI) | NCT03172559 | Hepatocellular ... | Stereotactic bo... | 18 Years - 75 Years | University Health Network, Toronto | |
| Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. | NCT02334709 | Carcinoma, Rena... | Stereotactic bo... | 18 Years - | University Hospital, Ghent | |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | NCT01511081 | Non-small-cell ... | SBRT (stereotac... SBPT (stereotac... | 18 Years - | M.D. Anderson Cancer Center | |
| WHOle Brain Irradiation or STEreotactic Radiosurgery for Five or More Brain Metastases (WHOBI-STER) | NCT04891471 | Neurocognitive ... Quality of Life Activities of D... | Stereotactic Ra... Whole Brain Irr... | 18 Years - | Mediterranean Institute of Oncology | |
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
| Stereotactic Body Radiotherapy for Head and Neck Tumors | NCT01344356 | Squamous Cell C... Nasopharyngeal ... Salivary Gland ... Head and Neck S... Paraganglioma o... Chordoma of Hea... Chondrosarcoma ... Angiofibroma of... | stereotactic bo... Stereotactic bo... | 18 Years - | Mercy Research | |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) | NCT02958163 | Liver Neoplasms Hepatocellular ... | Trans-arterial ... Doxorubicin Stereotactic Ab... | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma | NCT03312868 | Plasmacytoma | SBRT | 18 Years - 85 Years | Instituto do Cancer do Estado de São Paulo | |
| Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer | NCT03298087 | Newly Diagnosed... | radical prostat... stereotactic bo... Leuprolide apalutamide abiraterone | 18 Years - | VA Office of Research and Development |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
